4//SEC Filing
Ueno Ryuji 4
Accession 0000899243-17-022019
CIK 0001365216other
Filed
Sep 12, 8:00 PM ET
Accepted
Sep 13, 5:50 PM ET
Size
4.8 KB
Accession
0000899243-17-022019
Insider Transaction Report
Form 4
Ueno Ryuji
DirectorCEO, Chief Scientific Officer10% Owner
Transactions
- Sale
Class A Common Stock
2017-09-11$12.00/sh−1,000,000$12,000,000→ 8,006,585 total(indirect: By LLC)
Footnotes (1)
- [F1]On September 11, 2017, the reporting person sold 1,000,000 shares through a block trade pursuant to Rule 144 under the Securities Act of 1933, as amended.
Documents
Issuer
Sucampo Pharmaceuticals, Inc.
CIK 0001365216
Entity typeother
Related Parties
1- filerCIK 0001384370
Filing Metadata
- Form type
- 4
- Filed
- Sep 12, 8:00 PM ET
- Accepted
- Sep 13, 5:50 PM ET
- Size
- 4.8 KB